Role of PARP-2 in cardiac hypertrophy in rats

AIM: To investigate the expression of poly(ADP-ribose) polymerase-2 (PARP-2) during rat cardiac hypertrophy in vitro and in vivo, and to explore the effects of PARP-2 on the cardiac hypertrophy. METHODS: Abdominal aortic coarctation (AAC) was performed to establish a model of pressure overload-induced cardiac hypertrophy in SD rats. The expression of PARP-2 at mRNA and protein levels in the myocardium was determined by real-time PCR and Western blot. The hypertrophy model of the cardiomyocytes was induced by treating the cells with angiotensin Ⅱ (AngⅡ). PARP-2 was knocked down by siRNAs in neonatal rat cardiomyocytes and the cardiomyocyte hypertrophy was evaluated by measuring the mRNA levels of ANF, BNP, and β-MHC and the cellular surface area. RESULTS: The expression of PARP-2 at mRNA and protein levels was both increased in the AAC rats as compared with those in the sham animals. The expression of PARP-2 at mRNA and protein levels was also increased in a time- and concentration-dependent manner in AngⅡ-induced hypertrophy model of the cardiomyocytes. In the neonatal rat cardiomyocytes, knockdown of PARP-2 expression by siRNA attenuated AngⅡ-induced cardiac hypertrophy of the cardiomyocytes, indicating that endogenous PARP-2 played a positive regulatory role in cardiac hypertrophy. CONCLUSION: The mRNA and protein levels of PARP-2 increase in the in vitro and in vivo models of cardiac hypertrophy. Knockdown of PARP-2 protects cardiomyocytes from hypertrophy.     

Inhibition of Rac1 protects cardiac functions in STZ-induced diabetic cardiomyopathy through decreasing pho-p38 MAPK

AIM: To investigate the effects of Rac1 inhibition on the size of cardiomyocytes and left ventricular functions in diabetic cardiomyopathy. METHODS: Type 1 diabetes was induced in 8-week old C57 mice by streptozotocin (STZ, ip injection). Diabetic mice were treated with NSC23766, a specific inhibitor of Rac1 (STZ+NSC group, n=15) or without treatment (STZ group, n=15). Nondiabetic mice were used to serve as empty control (Con group, n=10) or NSC23766 control (NSC group, n=10). The survival rate, LVHW/BW and left ventricular functions were detected at the end of 8 weeks after induction of diabetes. The expression of ANP, BNP, β-MHC and pho-p38 MAPK in the cardiac tissues were analyzed by real-time RT-PCR and Western blotting, respectively. Hematoxylin and Eosin staining (HE) was used to measure the cell size in the cardiac tissues. RESULTS: The functions of left ventricle were significantly impaired in the diabetic animals with decreased survival rate and increased LVHW/BW, which was accompanied by significant increases in ANP, BNP and β-MHC, and elevated pho-p38 MAPK expression in diabetic hearts. The increased survival rate, improved left ventricular functions and decreased LVHW/BW were observed in the diabetic animals treated with NSC. The mRNA expression of ANP, BNP, β-MHC and pho-p38 MAPK was significantly attenuated in the diabetic hearts by NSC treatment. The size of the cardiomyocytes, which increased in diabetic hearts, was decreased in the NSC-treated diabetic cardiac tissue. CONCLUSION: Rac1 inhibition protects left ventricular functions and attenuates hypertrophy, which is associated with the decrease in pho-p38 MAPK expression in diabetic heart. These data suggest that inhibition of Rac1 might be beneficial to diabetic cardiomyopathy.     

Effects of myocardial extracts on transdifferentiation of bone marrow-derived mesenchymal stem cells of rats

AIM: To investigate the effects of myocardial extracts of rats on transdifferentiation of bone marrow-derived mesenchymal stem cells (MSCs). METHODS: After establishing stable culture methods for rat MSCs, they were induced by high level of myocardial extracts on day 3 of primary culture for 1 week. Immunocytochemistry technique was used to detect MHC and troponin-T, and the expression of Nkx2.5, α-MHC and ANP genes were identified by RT-PCR technique 3 weeks later. RESULTS: MSCs of rats expressed cardiac MHC and troponin-T proteins, Nkx2.5 and α-MHC genes after induction. However, they neither expressed ANP gene nor formed myotubes and intercalated disk. CONCLUSION: Myocardial extracts can induce MSCs to transdifferentiate into cardiomyocytes.     

Regulatory effect of miR-199a-5p on cardiomyocyte hypertrophy in rat

AIM：To investigate the expression of miR-199a-5p in rat cardiomyocyte hypertrophy models. METHODS：The in vivo cardiomyocyte hypertrophy model was established by transverse abdominal aortic constriction (TAAC) and the in vitro model was induced by angiotensin II. The content of miR-199a-5p was detected by qRT-PCR in the plasma of the TAAC rats and in the cardiomyocytes (CM) of the newborn rats. The CM was isolated and transfected with miR-199a-5p mimic or inhibitor at concentration of 100 nmol/L by Lipofectamine RNAiMAX. The mRNA levels of atrial natriuretic factor (ANF) and β-myosin heavy chain (β-MHC) were detected by qRT-PCR. Tritium-labeled leucine incorporation was employed to determine the protein synthesis rate in the CM. The method of cyto-fluorescent staining was applied to measure the changes of the CM surface area. RESULTS：Compared with control group, the content of miR-199a-5p significantly increased in the TAAC rats and in the CM induced by angiotensin II. In addition, over-expression of miR-199a-5p in the CM up-regulated the mRNA expression of ANF and β-MHC, accelerated the protein synthesis rate and enlarged the CM surface area. In the CM transfected with miR-199a-5p inhibitor following induced by angiotensin II, the hypertrophy effect receded inversely (P<0.05). CONCLUSION:Over-expression of miR-199a-5p may promote cardiomyocyte hypertrophy, and repression of miR-199a-5p may inhibit cardiomyocyte hypertrophy in the CM.     

Effect of rosuvastatin combined with irbesartan on remodeling of myocardial hypertrophy in rats

AIM: To evaluate the effect of rosuvastatin combined with irbesartan on the remodeling of myocardial hypertrophy in the rats. METHODS: Male SD rats(n=50) were randomly divided into control group, model group, rosuvastatin group, irbesartan group and combination group. The model of myocardial hypertrophy was established by subcutaneous injection of isoproterenol at dose of 2.5 mg/kg for 14 d. From the first day of modeling, the rats in control group and model group received intragastrical saline, and the rats in rosuvastatin group, irbesartan group and combination group were treated with rosuvastatin(4 mg·kg^-1·d^-1), irbesartan(15 mg·kg^-1·d^-1) and rosuvastatin(4 mg·kg^-1·d^-1)+ irbesartan(15 mg·kg^-1·d^-1), respectively. The interventions continued for 4 weeks. After the interventions, the cardiac mass index and left ventricular mass index of the SD rats were measured. Besides, the degree of myocardial hypertrophy was observed with HE staining. The mRNA expression of hypertrophy-related factors, such as ANF, β-MHC and AT1R was determined by RT-PCR, and the protein expression of AT1R was determined by Western blot. RESULTS: Compared with control group, the cardiac mass index, left ventricular mass index, as well as the mRNA expression of ANF and β-MHC in model group were significantly increased(P<0.05). Compared with model group, the above factors in rosuvastatin group and irbesartan group were decreased(P<0.05), and the factors in combination group were lower than those in rosuvastatin group and irbesartan group(P<0.05). In addition, the expression of AT1R at mRNA and protein levels in rosuvastatin group and irbesartan group was lower than that in model group(P<0.05), while the expression AT1R at mRNA and protein levels in combination group was lower than that in rosuvastatin group and irbesartan group(P<0.05). CONCLUSION: Rosuvastatin and irbesartan are equally effective drugs to resist the formation of myocardial hypertrophy by decreasing the expression of AT1R. Moreover, combination of the 2 drugs is more effective to improve the degree of myocardial hypertrophy than the 2 drugs alone.     

Inhibitory effect of aerobic exercise on left ventricular remodeling and sympathetic neural remodeling in rats with heart failure after myocardial infarction

AIM: To investigate the effects of long-term aerobic exercise on the heart and sympathetic neural remodeling (structure and function remodeling) in heart failure rats induced by myocardial infarction. METHODS: Heart failure model after myocardial infarction was performed by ligating anterior descending coronary artery in the Wistar rats. Four weeks after operation, the rats were randomly divided into sham operation sedentary (S) group, heart failure sedentary (H) group and heart failure exercise (HE) group. The animals in HE group underwent 10-week treadmill running, while those in S group and H group were sustained in a resting state. The cardiac structure and function including left ventricular internal diameter at diastole (LVIDd), left ventricular internal diameter at systole (LVIDs), left ventricular anterior wall diameter at diastole (LVAWDd), left ventricular anterior wall diameter at systole (LVAWDs), left ventricular posterior wall diameter at diastole (LVPWDd) and left ventricular posterior wall diameter at systole (LVPWDs), and cardiac function parameters including fractional shortening (FS) and left ventricular ejection fraction (LVEF) were measured by echocardiography. The myocardium was collected for histopathological observation with Masson staining, and the collagen volume fraction (CVF) was determined. The concentrations of norepinephrine (NE) in the myocardium and plasma were measured by high-pressure liquid chromatography. The frequency domain analysis was applied for determining the heart rate variability (HRV) via subcutaneous recording electrode involving total power (TP), normalized low power (LFn), normalized high power (HFn) and LF/HF ratio. The mRNA expression of collagen type I (Col-I), collagen type III (Col-III), atrial natriuretic factor (ANF), α-myosin heavy chain (α-MHC), β-myosin heavy chain (β-MHC), sarcoplasmic endoplasmic reticulum Ca²⁺-ATPase (SERCA2a) was detected by real-time PCR. The protein levels of nerve growth factor (NGF) and its receptor (TrkA), and tyrosine hydroxylase (TH) were measured by Western blotting. RESULTS: (1) Compared with S group, body weight (BW), LVIDd, FS, LVEF, TP, HFn, the mRNA expression of α-MHC and SERCA2a, and the protein levels of NGF, TrkA and TH decreased (P<0.05). Left ventricular weight (LVW), left ventricular mass index (LVMI), LVAWDd, LVAWDs, LVPWDd, LVPWDs, CVF, plasma and myocardial NE content, LFn, LF/HF, and the mRNA expression of ANF, β-MHC, Col-I and Col-III increased (P<0.05) in H group. (2) Compared with H group, LVW, LVMI, LVIDd, FS, LVEF, TP, HFn, the mRNA expression of α-MHC and SERCA2a, and the protein levels of NGF, TrkA and TH were raised (P<0.05), while CVF, plasma and myocardial NE content, LFn, LF/HF, and the mRNA expression of ANF, β-MHC, Col-I and Col-III decreased (P<0.05) in HE group. CONCLUSION: Long-term aerobic exercise training leads to inhibition of heart and sympathetic neural remodeling and improvement of cardiac function and autonomic modulation in the rats after myocardial infarction.     

High glucose induces H9c2 cardiomyocyte hypertrophy through Ca2+-CaN-NFAT3 signaling pathway

AIM: To study the morphological changes of cardiac H9c2 cells during the developmental process of fetal rat. METHODS: Embryonic rat heart-derived H9c2 cells were maintained in DMEM supplemented with 10% fetal bovine serum. The H9c2 cells were plated at a density of 6000 cells/cm and divided into 5 groups: H9c2 cells were treated with 5 mmol/L glucose, 25 mmol/L glucose, 50 mmol/L glucose, Norvasc (25 nmol/L)+25 mmol/L glucose, or Norvasc (25 nmol/L)+50 mmol/L glucose for 48 h. The morphology of H9c2 cells was observed. The cell surface area was measured by Image-Pro Plus 6.1 software. Fluorescence spectrophotometry was used to detect the concentration of intracellular calcium ion ([Ca²⁺]_i)in the cardiomyocytes. The concentration of CaN in the cell was measured by ELISA. The mRNA expression of CaNAβ, NFAT3 and β-MHC in the cells was detected by real-time PCR. The protein levels of CaNAβ, NFAT3 and β-MHC in cultural H9c2 cells were detected by Western blot. RESULTS: The mean area of the cells, the mean fluorescence value of [Ca²⁺]_i and the concentration of CaN in 25 mmol/L glucose group were higher than those in 5 mmol/L glucose group, and those were lower than those in 50 mmol/L glucose group. After treated with Norvasc, those results decreased significantly. The expression of CaNAβ, NFAT3 and β-MHC at mRNA and protein levels in 25 mmol/L glucose group was higher than those in 5 mmol/L glucose group, but was lower than those in 50 mmol/L glucose group. The expression of CaNAβ, NFAT3 and β-MHC at mRNA and protein levels decreased significantly in Norvasc treatment group. CONCLUSION: Ca²⁺-CaN-NFAT3 signaling pathway is perhaps involved in high glucose-induced H9c2 cardiomyocyte hypertrophy.     

Protective role of carnosine on cardiac dysfunction in type 1 diabetes mellitus rat model

AIM:To explore the effects of carnosine (CAR) on cardiac dysfunction in type 1 diabetic mellitus rats and the underlying mechanism. METHODS:The SD rats were randomly divided into 4 groups:control (C) group, control+carnosine (C+CAR) group, diabetes mellitus (DM) group and diabetes mellitus+carnosine (DM+CAR) group (n=10). The rats were sacrificed after 12 weeks. The cardiac function was assessed by ventricular cannulation. The activity of superoxide dismutase (SOD) and the content of malondialdehyde (MDA) were assessed by ELISA. The mRNA levels of tumor necrosis factor α(TNF-α), interleukin-1β(IL-1β) and IL-6 were measured by real-time PCR. The distribution of connexin 43 (Cx43) was examined by immunofluorescence. The protein levels of Cx43 and protein kinase C (PKC) were determined by Western blot. RESULTS:Compared with the C group, the left ventricular end diastolic pressure (LVEDP) was increased whereas the left ventricular pressure maximum rise/fall velocity (±dp/dt_max) was decreased in the DM group (P<0.01). The activity of SOD decreased while the MDA increased in the left ventricular tissues (P<0.01). The mRNA levels of TNF-α, IL-1β and IL-6 were increased (P<0.01). The Cx43 distribution was irregular. The protein levels of phosphorylated Cx43 and PKCε were elevated (P<0.01). Compared with the DM group, the cardiac function of LVEDP and ±dp/dt_max in DM+CAR group was ameliorated (P<0.01), with increased SOD activity and decreased MDA content (P<0.05). The mRNA levels of TNF-α, IL-1β and IL-6 were reduced (P<0.01). The Cx43 distribution was improved and the protein levels of phosphorylated Cx43 and PKCε were decreased (P<0.01). CONCLUSION:CAR treatment can improve the cardiac function by its anti-oxidative and anti-inflammation effects and suppression of Cx43 abnormalities through PKCε in DM rats.     

Quercetin inhibits inflammasome activation in diabetic rats and attenuates myocardial injury

AIM:To observed the effect of quercetin on NLRP3 inflammasome activation in the rats with diabetic cardiomyopathy (DCM) and its protective effect on the myocardium. METHODS:Male SD rats (n=40) were randomly divided into normal control group (n=10) and model group (n=30). The rats in model group were intraperitoneally injected with streptozotocin at 60 mg/kg to establish the model of diabetes mellitus (DM). Blood glucose was measured weekly. After 4 weeks, the rats with random blood glucose ≥ 16.6 mmol/L were selected as DM animals. The rats with DM were randomly divided into 3 groups:DM group, DM+vehicle group and DM+quercetin group. The rats in DM+quercetin group were intragastric infusion with quercetin at 100 mg/kg per day. The cardiac function was measured at the end of the 16th week. The methods of Masson staining and HE staining were used to observe the morphological changes of the myocardial tissues. Western blot, ELISA and immunohistochemistry were used to observe the changes of NLRP3, ASC, caspase-1, interleukin (IL)-1β and IL-18. TUNEL staining was used to observe myocardial apoptosis. RESULTS:Quercetin significantly inhibited the activation of NLRP3 inflammasome in the myocardium of the DM rats (P<0.05). The levels of IL-1β and IL-18 in DM+quercetin group were significantly decreased, quercetin reduced cardiac tissue apoptosis, and the cardiac function in DM+quercetin group was significantly improved (P<0.05) compared with DM group and DM+vehicle grpup. CONCLUSION:Quercetin significantly inhibits the activation of NLRP3 inflammasome, and reduces the levels of inflammation and myocardial apoptosis, thus protecting the heart function of DCM rats.     

Potential mechanism of myocardium apoptosis of right ventricle in rat under chronic hypoxia

AIM:We used an animal model of chronic hypoxia to mimic right ventricular hypertrophy and try to study the potential mechanism of myocardium apoptosis of right heart in rat under chronic hypoxia. METHODS: Rat hypoxia models were established by exposing the rats to normobaric chronic hypoxia (oxygen levels were maintained at 9.5%-10.5%). Sixty rats were separated into two groups: one exposed to hypoxia and the other serving as control. Ten rats, randomly selected from each group were killed at 14, 21, 28 d after hypoxia. The apoptosis was determined. The changes of RV weight to left ventricle and interventricular septum weight ratio［RV/(LV+S)］, the RV weight to body weight ratio (RV/BW) were also observed. The β-MHC, bcl-2 and bad mRNA levels in right ventricle were detected by semi-quantitative RT-PCR assays and expression of β-MHC, Bcl-2 and Bad protein levels were detected by Western blotting.RESULTS: The RV/(LV+S), RV/BW and apoptosis index in chronic hypoxia group were higher than those in normal control group (P<0.01). The results of RT-PCR and Western blotting showed that β-MHC mRNA levels and protein levels in chronic hypoxia group were higher than those in normal control group (P<0.01). The rate of apoptosis, the RV/(LV+S), RV/BW and the expression of β-MHC in hypoxia group all increased with time. The bcl-2 mRNA and Bcl-2 protein expressions in chronic hypoxia group were lower compared with control group at 14, 21 and 28 d (P<0.05). In contrast, no significant change of bad mRNA and Bad protein expressions in chronic hypoxia group were observed compared with control group (P>0.05). Finally, a decreased bcl-2/bad〖STBZ〗 ratio in chronic hypoxia group was found compared with control group (P<0.05). Both the expression of bcl-2 and the bcl-2/bad ratio decreased with time (P<0.05).CONCLUSION:These data demonstrate that chronic hypoxia may induce right ventricular hypertrophy, as well as cardiomyocytes apoptosis. Furthermore, apoptosis in hypertrophic cardiomyocytes induced by hypoxia is mainly due to the inhibition of bcl-2 expression and decrease of bcl-2/bad ratio.     

Effect of captopril and betaloc on the changes in expression of MHC of left ventricle in hypertensive rats

AIM:To investigate myosin heavy chain(MHC)gene expression and the effects of captopril and betaloc at an early stage of hypertension. METHODS:Model of hypertension was made by partly narrowing two bilateral renal arteries(2K2C). The rats were divided into four groups at random. (1) control group; (2)2K2C group;(3)captopril group;(4)betaloc group.Levels of α-MHC and β-MHC mRNA were determined by dot-blot. RESULTS:α-MHC mRNA expression were gradual1y reduced in 2K2C group, while β-MHC mRNA expression were increased, and the marked changes were observed at 72h postoperation. Captopril could inhibit the changes in MHC gene expression; but betaloc could not. CONCLUSION: The expression of MHC gene has changed at an early stage of renal hypertensive rat, and renin-angiotensin system may play an important role in this change.     

Yunpiheluo decoction alleviates diabetic kidney injury by regulating Sirt1/AMPK signaling pathway and activating autophagy

AIM: To observe the effect on Yunpiheluo decoction (YPHL) on renal injury in type 2 diabetic rats and to explore the mechanism from the perspective of Sirt1-AMPK-autophagy. METHODS: Male Zucker diabetic fatty (ZDF) rats (n=24) were randomly divided into model group, Sirt1 over-expression group and YPHL group, and fed with high-fat and high-sugar diet for 10 weeks. ZL rats were used as normal control and fed with normal diet for 10 weeks. After 10 weeks, urine and blood were collected for renal function detection. The rats were sacrificed and specimen was submitted. In addition, the mRNA expression of Sirt1 was analyzed by real-time PCR. The protein levels of Sirt1, AMPK, p-AMPK, LC3 and P62 in the renal tissues wene determined by Western blot. The renal pathological changes were observed under light microscope with HE and Masson staining. RESULTS: Compared with control group, fasting blood glucose (FBG), urinary protein (UP), urinary albumin (U-ALB) and serum creatinine (SCr) in model group were obviously increased (P<0.01). The mRNA expression of Sirt1 was decreased (P<0.05). The protein levels of SIRT1, AMPK, p-AMPK and LC3-II/-I were decreased (P<0.01), and P62 was increased (P<0.01). Glomerular focal fibrosis, focal renal tubular epithelial cell vacuolation, necrosis, shedding and atrophy, tubular type, and renal interstitial fibrosis were observed. Compared with model group, FBG was obviously decreased in Sirt1 over-expression group (P<0.01), but it showed no significant change in YPHL group (P>0.05). SCr and U-ALB were decreased (P<0.05), Sirt1 mRNA was increased (P<0.05), the protein levels of SIRT1, AMPK, p-AMPK and LC3-II/-I were increased (P<0.01), and P62 was decreased (P<0.01) in Sirt1 over-expression group and YPHL group. HE and Masson staining showed that the renal damage in Sir1 over-expression group and YPHL group was attenuated. CONCLUSION: Yunpiheluo decoction may protect the kidney by increasing the expression level of Sirt1, activating AMPK, and regulating autophagy.     

Long-term insulin treatment improves postischemic cardiac structure and function via increasing serum BNP levels

AIM：To investigate the influence of long-term insulin treatment on postischemic cardiac structural and functional changes, and to further explore the underlying mechanisms. METHODS：Adult male SD rats were randomly divided into 4 groups (8~10 rats per group): sham group, myocardial infarction (MI) + saline (1 mL·kg-1·d-1, hypodermic injection for 4 weeks) group, MI + insulin (2 U·kg-1·d-1, hypodermic injection for 4 weeks) group and MI + insulin (2 U·kg-1·d-1, hypodermic injection for 4 weeks) + wortmannin ［a phosphatidylinositol 3-kinase (PI3K) inhibitor; 15 μg·kg-1·d-1, intraperitoneal injection 15 min before each insulin treatment］ group. The rats in the latter 3 groups were subject to ligation of the left anterior descending coronary artery, while those in sham group underwent the same surgical procedures without tying the sutures. The cardiac structural and functional changes were observed by echocardiogram, heart catheterization and microscopy with HE and Masson trichrome staining. Blood glucose was determined by Roche blood glucose meter, and the serum levels of insulin and brain natriuretic peptide (BNP) were detected by ELISA. The protein expression and phosphorylation of PI3K, Akt, glycogen synthase kinase 3β (GSK3β) and p38 mitogen-activated protein kinase (p38 MAPK) in myocardial tissues were detected by Western blotting. The mRNA expression of BNP, β-myosin heavy chain (β-MHC) and atrial natriuretic peptide (ANP) in myocardial tissues was determined by real-time fluorescence quantitative PCR. RESULTS：At the end of the 4th week, MI rats receiving long-term insulin treatment showed decreased ratio of heart length/heart weight, smaller systolic left ventricle cavity, thicker systolic interventricular septum, and increased cardiac ejection fraction, left ventricular development pressure and instantaneous first derivate of left ventricle pressure (P<0.05 vs MI + saline group). Moreover, insulin treatment significantly increased the phosphorylation of PI3K and Akt and the serum level of BNP, and inhibited the phosphorylation of p38 MAPK (P<0.05 vs MI + saline group), but did not change the mRNA expression of BNP in myocardial tissues. The effects of insulin on BNP were not blocked by wortmannin (P>0.05 vs MI + insulin group). CONCLUSION：Insulin improves postischemic cardiac structure and function by increasing serum BNP levels possibly independent of PI3K-Akt signaling pathway.     

Effects of PPARα activation on AngⅡ-induced cardiomyocyte hypertrophy and interaction of NFATc4 with p65-NFκB

AIM：To investigate the effects of fenofibrate on angiotensin Ⅱ (AngⅡ)-induced cardiomyocyte hypertrophy. METHODS：Primary neonatal cardiomyocytes were pretreated with fenofibrate (10 μmol/L) for 1 h followed by stimulation with AngⅡ (100 nmol/L). The mRNA levels of ANF, BNP and β-MHC were measured by real-time PCR. Western blotting was employed to determine the nuclear translocations of NFATc4 and p65-NFκB. Co-immunoprecipitation was used to investigate the interaction of NFATc4 with p65-NFκB in the nucleus of cardiomyocytes. In addition, the DNA binding activity of NFATc4 on the BNP promoter was determined by EMSA. RESULTS：Fenofibrate significantly inhibited AngⅡ-induced cardiomyocyte hypertrophy. Fenofibrate treatment inhibited the nuclear translocations of NFATc4 and p65-NFκB, as well as the interactions of NFATc4 with p65-NFκB in the nucleus of cardiomyocytes induced by AngⅡ. Fenofibrate inhibited the binding activity of NFATc4 with the BNP promoter, which was strengthened by AngⅡ. CONCLUSION： Fenofibrate enhances the interaction of NFATc4 with PPARα, decreases the interaction of NFATc4 with p65-NFκB in the nucleus of cardiomyocytes, and inhibits the DNA binding activity of NFATc4 induced by AngⅡ, which may be the important mechanisms of fenofibrate on inhibiting cardiac hypertrophy.     

Synergistic effect of hypertension and type 2 diabetes on cardiac dysfunction and myocardial remodeling in mice

AIM: To investigate whether the effect of hypertension combined with diabetic can lead to cardiac dysfunction and myocardial remodeling in mice. METHODS: The diabetic mice and non-diabetic mice of 14 weeks old were administered with PBS or angiotensin II (Ang II) for 4 weeks to induce mild hypertension. The left ventricular (LV) function was assessed by echocardiography and dobutamine stress test. The LV tissues were subjected to HE staining to assess cardiac hypertrophy. The phospharylated adenosine monophosphate-activated protein kinase (p-AMPK) levels in the LV tissues were determined by Western blotting. RESULTS: Compared with control group, diabetic mice (DM group) neither displayed marked cardiac dysfunction nor myocardial remodeling. Ang II treatment did not affect body weight and glucose level, but the blood pressure was increased in the diabetic and control mice. Ang II-induced LV hypertrophy in diabetic mice was significantly higher than that in control mice as assessed by LV masses and cardiomyocyte sizes. Moreover, Ang II-treatment reduced LV fractional shortening and contractility in the diabetic mice, but not in the control mice. The p-AMPK levels were significantly reduced in Ang II group, DM group and DM+Ang II group. CONCLUSION: The cardiac function and cardiac structure of type 2 diabetic mice did not obviously change. Cardiac dysfunction and myocardial remodeling were easily induced in type 2 diabetic mice when hypertension happened, suggesting that hypertension is a critical factor of cardiac dysfunction and myocardial remodeling in type 2 diabetic mice.     

Changes of aryl hydrocarbon receptor in cardiac hypertrophy induced by high glucose in vitro

AIM: To investigate the changes of aryl hydrocarbon receptor (AhR) in the process of cardiomyocyte hypertrophy induced by high glucose, and to explore its potential mechanisms. METHODS: The rat cardiomyocytes (H9c2 cells) were divided into normal glucose group, high glucose group, DMSO group and resveratrol (an AhR antagonist) group. The content and distribution of AhR were observed with immunofluorescence staining. The myocardial cells were stained with rhodamine-labeled phalloidin to visualize cytoskeleton, and the cell surface area were determined after imaging by fluorescence microscopy. The generation of reactive oxygen species (ROS) in the cardiomyocytes was measured using a fluorescent probe DCFH-DA. The mRNA expression of AhR, CYP1A1, atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) were evaluated by real-time quantitative PCR (RT-qPCR). The protein levels of AhR, CYP1A1, ANP and BNP were assessed by Western blot. RESULTS: AhR was constitutively presented in the cytosol under normal-glucose condition and was translocated to the nuclei under high-glucose condition. High glucose induced cardiac hypertrophy, and increased ROS generation. Significant reductions in the cell size and ROS generation were observed after treated with resveratrol. The expression of AhR, CYP1A1, ANP and BNP at mRNA and protein levels in high glucose group was increased as compared with normal glucose group and resveratrol group, and the above-mentioned indexes significantly decreased in resveratrol group as compared with DMSO group. CONCLUSION: High glucose-induced cardiac hypertrophy increases AhR expression, which may be involved in the maintenance of glucose homeostasis in the cardiomyocytes. AhR translocation to the nucleus induced by high glucose results in the increases in CYP1A1 expression and ROS generation, which may be an important mechanism of high glucose-induced cardiomyocyte hypertrophy.     

The protective effects of angiotensin Ⅱ receptor blocker irbesartan on kidney function in diabetic rats

AIM: To investigate the effects and mechanisms of irbesartan, one of the angiotensin Ⅱreceptor blockers, on kidney function in diabetic rats. METHODS: Forty adult male Wistar rats were randomly divided into four groups: control group, diabetes group, irbesartan group and captopril group. At the end of 12 weeks, the rats were sacrificed. Urine volume, body weight, kidney weight/body weight, plasma, glucose, glycosylated hemoglobin (HbA₁c), urinary β₂-microglobulin (β₂-MG) excretion, urinary albumin excretion rate (UAR), creatinine clearance (Ccr) were measured. Nitric oxide (NO) and endothelin-1 (ET-1) levels in plasma, urinary and renal tissues were determined. RESULTS: Urine volume, kidney weight/body weight, plasma glucose, HbA1C, UAR, Ccr, urinary β₂-MG excretion, NO and ET-1 levels of urinary, blood and renal tissue in diabetic rats were significantly higher than those of normal controls ( P<0.01). UAR, Ccr, urinary β₂-MG excretion, ET-1 and NO levels of urinary and renal tissue in rats of irbesartan and captopril groups were significantly lower than those of DM rats ( P<0.01). There were positive relationships among the levels of plasma, urinary, renal tissue ET-1, NO and UAR, Ccr and urinary β₂-MG excretion. CONCLUSION: Irbesartan could prevent from the injury of renal function in STZ-induced diabetic rats. And it maybe one of the most importan mechanisms that irbesartan could reduce the NO and ET-1 levels in STZ-induced diabetic rats.